Deep Vein Thrombosis Market: Market Size, Scope, and Growth Factors Driving Industry Expansion

The new report published by The Business Research Company, titled Deep Vein Thrombosis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the deep vein thrombosis market size has grown steadily in recent years. It will grow from $1.03 billion in 2023 to $1.07 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The deep vein thrombosis market size is expected to see steady growth in the next few years. It will grow to $1.26 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp

Rising Demand For Deep Vein Thrombosis (DVT) Treatment Drives Market Growth
The increasing number of individuals who require deep vein thrombosis (DVT) treatment is expected to propel the growth of the deep vein thrombosis market going forward. DVT treatment refers to treating patients with deep vein thrombosis using drugs such as anticoagulants and others that prevent the formation of new blood clots and existing blood clots from getting larger, alleviating the disease condition. The increase in the number of patients requiring DVT treatment indicates an increase in the prevalence of deep vein thrombosis that requires products for DVT diagnosis, prevention, and treatment. For instance, in February 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, an overall 900,000 people could be affected each year in the United States due to deep vein thrombosis, and between 60,000 and 100,000 Americans die each year from DVT or PE (pulmonary embolism). Therefore, the increasing number of individuals requiring deep vein thrombosis (DVT) treatment is driving the market.

Companies Unveil Revolutionary Mechanical Thrombectomy System With Lightning Flash Technology To Driving Innovations In Deep Vein Thrombosis Market
Product innovations are a key trend gaining popularity in the deep vein thrombosis market. Major companies operating in the deep vein thrombosis market are adopting new technologies to develop new product and to sustain their position in the market. For instance, in January 2023, Penumbra Inc., a US-based developer of innovative therapies, launched Lightning Flash, an advanced and powerful mechanical thrombectomy system for addressing venous and pulmonary thrombus. The system features Penumbra's novel lightning-intelligent aspiration technology and innovative dual clot detection algorithms. It is designed to quickly remove large blood clots in the body, including venous thrombus and pulmonary emboli (PE). It provides physicians with a high torque-able, larger catheter designed for efficiently removing a significant clot burden in the pulmonary arteries or deep venous system while maintaining an excellent safety profile.

The deep vein thrombosis market covered in this report is segmented -

1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10616&type=discount

Major companies operating in the deep vein thrombosis market report are Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Momenta Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Altimed Ltd., Teva Pharmaceutical Industries Ltd., Swiss Pharma Private Limited, Laurus Labs Limited, AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Koninklijke Philips N.V., Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Lonza Group AG, Pfizer Inc.

Contents of the report:
1. Executive Summary
2. Deep Vein Thrombosis Market Report Structure
3. Deep Vein Thrombosis Market Trends And Strategies
4. Deep Vein Thrombosis Market - Macro Economic Scenario
5. Deep Vein Thrombosis Market Size And Growth
…..
27. Deep Vein Thrombosis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.